{"id":"W4200249070","doi":"10.51731/cjht.2021.225","title":"Pembrolizumab (Keytruda)","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Pembrolizumab; Medicine; Refractory (planetary science); Drug; Family medicine; Intensive care medicine; Internal medicine; Pharmacology; Political science; Cancer; Health care; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006536826,0.0002717398,0.0002693856,0.0006874842,0.0002584937,0.0008526077,0.000364567,0.0005340643,0.01327232],"category_scores_gemma":[0.001006986,0.0000886365,0.0004096887,0.0004667259,0.000281606,0.0005867559,0.0003614417,0.0007500781,0.002643097],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001757063,"about_ca_system_score_gemma":0.002159606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01744737,"about_ca_topic_score_gemma":0.05461993,"domain_scores_codex":[0.999694,0.00006298596,0.00003321267,0.00004441622,0.0001180894,0.00004728014],"domain_scores_gemma":[0.999653,0.00007365082,0.00008822704,0.00001481646,0.0001230746,0.00004731428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004462334,0.00005199585,0.0005330602,0.003170398,0.0001022852,0.0001436091,0.00002737137,0.0001158925,0.003523541,0.003644153,0.07823038,0.9100112],"study_design_scores_gemma":[0.000223845,0.0005032301,0.004125999,0.002324597,0.0001747455,0.0007604051,0.00004004029,0.0001024235,0.004307703,0.0005815132,0.9868404,0.00001516159],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.009356791,0.851905,0.001707226,0.0123791,0.002157207,0.0002442559,0.001992245,0.0002583732,0.1199998],"genre_scores_gemma":[0.1361045,0.7271405,0.006635461,0.01436069,0.001070379,0.0002696136,0.00290777,0.00004650916,0.1114647],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01744737,"threshold_uncertainty_score":0.04440033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02783858150882862,"score_gpt":0.294519728736736,"score_spread":0.2666811472279074,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}